Vericel Reports Record Third Quarter Revenues of $22.5 Million and Raises Full Year 2018 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Vericel Corporation (VCEL) PT Raised to $20 at BTIG
November 6, 2018 1:16 PM ESTBTIG analyst Ryan Zimmerman raised the price target on Vericel Corporation (NASDAQ: VCEL) to $20.00 (from $17.00) while maintaining a Buy rating following strong results driven by both MACI and Epicel growth.
Zimmerman said the guidance raise was 'encouraging' as both biopsy growth and expanding... More
Vericel (VCEL) Tops Q3 EPS by 9c, Revenues Beat; Raises FY18 Revenue Guidance Above Consensus
November 6, 2018 7:41 AM ESTVericel (NASDAQ: VCEL) reported Q3 EPS of ($0.02), $0.09 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $22.5 million versus the consensus estimate of $18.14 million.
We achieved record third quarter revenues and our consistently strong revenue growth has generated significant improvements in... More
